Viewing Study NCT02411695


Ignite Creation Date: 2025-12-24 @ 1:57 PM
Ignite Modification Date: 2026-02-06 @ 6:22 AM
Study NCT ID: NCT02411695
Status: COMPLETED
Last Update Posted: 2017-02-15
First Post: 2014-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adolescent View
None Otsuka, View
None Brexpiprazole View